Physician profile
Mark W Kovach
NPI 1336128222
$10,474.68
in general payments reported to CMS, 2019-2025
20 companies · $227 in 2025
The $227 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,337 · 2020: $712 · 2021: $378 · 2022: $3,599 · 2023: $1,129 · 2024: $93.21 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $765 · Travel and Lodging: $684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $765.22 |
| Travel and Lodging | $683.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,124.05 | 2019-2025 | Ensite, Merlin@Home |
| Medtronic Vascular, INC. | $2,791.15 | 2019-2020 | |
| Boston Scientific Corporation | $1,555.20 | 2019-2025 | Watchman Access System, General - Tachy, Dynagen Mini Icd Vr |
| Inari Medical, INC. | $1,254.20 | 2022 | |
| Cook Incorporated | $702.46 | 2023 | Evolution |
| Zoll Respicardia, INC. | $323.42 | 2019-2020 | |
| Cook Medical LLC | $237.62 | 2019-2023 | Evolution |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $159.86 | 2019-2025 | Lifevest |
| Atricure, INC. | $83.24 | 2019 | |
| Cardiva Medical, INC. | $48.52 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Philips North America LLC | $37.51 | 2019-2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Biotronik INC. | $28.11 | 2019 | |
| Genzyme Corporation | $22.97 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.26 | 2025 | Jardiance |
| Teleflex LLC | $16.48 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $16.43 | 2021 | |
| Biosense Webster, INC. | $14.74 | 2025 | Carto 3 |
| Kiniksa Pharmaceuticals, Ltd. | $13.95 | 2021 | |
| Scpharmaceuticals INC. | $13.67 | 2025 | |
| Novartis Pharmaceuticals Corporation | $12.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Kovach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.